Navigation Links
Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
Date:3/17/2008

s time, he successfully advised Life Sciences clients on transactions valued at US$ billions, as well as working on many successful M&A transactions in the Specialty Chemicals sector. Dean qualified as a Chartered Accountant in the UK with BDO Binder Hamlyn.

Dean Brown, Principal and Co-Founder of Marquant, said: "We are excited by MTI's unique AMPK program and the potential to address major therapeutic sectors with genuine unmet need in healthcare today. Neal and his team have done a great job in progressing the lead series in diabetes so quickly and I believe that the experience and industry connections that Marquant brings will enable us to spread the MTI story widely and attract high profile partners prepared to commit to financially attractive transactions."

Neal C. Birnberg, Ph.D., MTI's CEO, said: "We are pleased to have selected Marquant Partners as Mercury's agents to obtain the best deal value available for the Company and its program in Type-2 diabetes. Along with their extensive network of industry contacts, the principals at Marquant represent the type of professionals that we at Mercury believe will best represent our interests in the investment and business development communities."

About Mercury Therapeutics, Inc. (http://www.mtipharm.com)

MTI was launched in 2001, and has an exclusive license to a patent from Dartmouth College and St. Vincent's Institute for Biomedical Research in Melbourne, Australia for AMP activated protein kinase (AMPK). In June 2001, MTI launched its R&D operations following execution of a sub-license and collaboration agreement with Aventis to develop AMPK activators to treat Type-2 diabetes and obesity. In June 2004, Aventis was acquired by Sanofi, and the AMPK collaboration with MTI ended. In October, 2004: MTI secured external financing from XL TechGroup, Inc. In Q4 2005, MTI demonstrated its first preclinical proof-of-principle of active compou
'/>"/>

SOURCE Mercury Therapeutics Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Mercury Therapeutics, Inc: Lead Series of Indirect AMPK Activators Licensed to Makoto Life Sciences
2. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
3. Cell Therapeutics, Inc. Takes Corrective Actions in Response to Nasdaq Determination
4. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
5. Nile Therapeutics, Inc. Adds to Executive Management Team
6. Cell Therapeutics, Inc. (CTI) Receives SPA Approval from FDA and Launches Gender-Specific Phase III Trial for Advanced Non-Small Cell Lung Cancer
7. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
8. Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results
9. Northwest Biotherapeutics, Inc. Announces Appointment of Chief Financial Officer
10. Nile Therapeutics, Inc. to Present at Upcoming BIO Investor Forum
11. Hyperion Therapeutics, Inc. Announces Senior Management Team and $15M Financing Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...
(Date:5/21/2013)... Emerson Resources Inc. , a premier pharmaceutical ... Company’s Chief Executive Officer and Chairman of the Board, ... service. As part of Emerson Resources’ planned leadership succession ... as Dr. Signorino’s successor. , Dr. Signorino is ... a significant contribution to the field during his extensive ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013  Synthetic Biologics, ... the prevention and treatment of serious infectious diseases, announced today ... at the 2 nd Annual Marcum LLP MicroCap Conference ... City at the Grand Hyatt Hotel. Mr. Riley ... A live webcast of Synthetic Biologics, presentation can be ...
(Date:5/21/2013)... 21, 2013 Bed bugs have become so ... Cleaning Products, many turn to chemical-based pesticides for help to ... and environmental risks those solutions present, the company advised the ... Bully instead. , According to My Cleaning Products, chemical-based ... used to be. It shared that the pests have already ...
Breaking Biology Technology:The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2Emerson Resources Announces CEO Retirement and Appointment of Successor 2Emerson Resources Announces CEO Retirement and Appointment of Successor 3Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 2New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests 3
... Inc. (OTC:,NNLX) a nano-biotechnology company announces that ... articles on the NanoLogix hydrogen,bioreactor technology under ... produced by Lisa Ann Pinkerton under the ... on various affiliated NPR stations,February 4th. The ...
... in Prostate, Lung and Brain Tumor ... ... a global leader in the field of radiosurgery,today announced key clinical presentation ... 2008 in,Scottsdale, Ariz., At this year,s CyberKnife Users, meeting eight presentations ...
... RDEA ) today announced that Barry D. Quart, PharmD, ... Capital Partners,20th Annual OC Growth Stock Conference., ... Pacific Time Location: The Ritz Carlton Laguna Niguel, ... http://www.ardeabio.com About Ardea Biosciences, ...
Cached Biology Technology:National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welch's Foods 2CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 2CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 3CyberKnife Users' Meeting Highlights Major Clinical Data Milestones and Emerging Trends 4Ardea Biosciences to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference 2
(Date:5/20/2013)... at the University of Bristol and published online today ... light on how the brain and inner ear developed ... of Earth Sciences, together with Tom Hbner from the ... 150 million year old dinosaurs. , The two palaeontologists ... lettowvorbecki : a very young (juvenile) individual of ...
(Date:5/18/2013)... MD (May 19, 2013) The AGA Research Foundation ... and Damian Augustyn Award in Digestive Cancer, which will ... of Medicine at the University of Pennsylvania, Philadelphia, as ... in pancreas development, regeneration and cancer progression. , "The ... in honor of two distinguished clinicians and AGA Legacy ...
(Date:5/17/2013)... provide the white noise of the South, but the night ... Southern air hangs heavy from the humidity and the sounds ... 140 species of frogs, toads and salamanders, is the center ... and swamps are the auditorium for their symphonic choruses, the ... Initiative, or ARMI, have front-row seats. , Amphibians, ...
Breaking Biology News(10 mins):Fossil brain teaser 2AGA Research Foundation grant furthers digestive cancer research 2Front-row seats to climate change 2Front-row seats to climate change 3Front-row seats to climate change 4
... Many children in the U.S. have poor diets and ... struggle to have meals together with children and provide them ... foods. Jayne Fulkerson, associate professor at the University of ... project grant (R01) from the National Institutes of Health for ...
... Wind turbines may be one of the best renewable ... get noisier, become more of an eyesore, and require ... turbines. While offshore turbines already have been constructed, they,ve ... extends directly into the seabed. That restricts the turbines ...
... of laboratory mice characterized at Penn State University has behavioral, ... human patients with drug-resistant forms of depression. The mice ... expected to be useful as a new model organism in ... of depression. The research, led by Bernhard Luscher, a ...
Cached Biology News:Dr. Jayne Fulkerson receives $3.2 million NIH grant 2Dr. Jayne Fulkerson receives $3.2 million NIH grant 3Depressed mice could aid research on drug-resistant depression in humans 2Depressed mice could aid research on drug-resistant depression in humans 3Depressed mice could aid research on drug-resistant depression in humans 4
... The PowerEase 500 Power Supply ... electrophoresis. It offers extensive programming ... four custom methods for you ... preferences. The simple intuitive PowerEase ...
Eliminate electrical interference from any analog signal, without filtering. Ideal for electrophysiology applications like EKG, EMG, and EEGs. Removes 50/60hz noise and harmonics caused by grounding ...
Request Info...
... The Light Diagnostics Universal ... intended for use in the ... DNA generated by in ... research use only; not to ...
Biology Products: